Trade & Exports

China's export machine is still running on industrial-policy capacity, and Washington's answer is escalation rather than routine upkeep. The newest evidence is national in scale — the National Bureau of Statistics' August readout — while the sharpest new US action carries retroactive bite. Direction unchanged, but the mechanism is now visible at full-country level and the remedy net is getting teeth.

The NBS August data is the overcapacity signature in one release. Industrial value added rose 5.2% year-on-year and 5.3% for January-August; equipment manufacturing grew 12.1% and high-tech manufacturing 16.7%, both far faster than the headline, with computer/communications/electronics at 17.2% and rail/ship/aerospace at 13.4% ^1,2. Output of lithium-ion batteries jumped 57.2%, industrial robots 34.6%, 3D printing equipment 29.9%; new energy vehicles hit 1.647 million units, up 21.9%, even as autos overall fell 2.7% ². Steel dropped 5.5% and cement 11.7%. Targeted strategic sectors run hot while legacy heavy industry contracts — and the NBS itself flags 'rapid foreign trade growth' as the outlet ¹. That surplus has to land somewhere, and it lands abroad.

The US side escalated on 15 September. Commerce issued a preliminary affirmative countervailing-duty determination on tin mill products from China — paired with a preliminary affirmative critical circumstances determination and alignment of the final CVD with the final antidumping determination ³. Critical circumstances is the operative phrase: it opens the door to retroactive duties, a step past the routine widening seen in the same batch, where the steel racks review merely published final results and partial rescission of the 2023-2024 administrative review ⁴. The ITC also received a fresh Section 337 complaint and solicited public-interest comments ⁵, keeping the non-tariff channel active alongside the duty docket.

Liaoning remains the cleanest measured proof that diversification is producing numbers, not just promises. January-August trade hit a same-period record of 527.4 billion yuan, up 5.1%, with exports up 13.4% to 303.6 billion ⁶. ASEAN stayed the top partner at 97.2 billion, up 19.1%, the EU second at 84.5 billion, up 8.5%, Latin America up 14.5%, Africa up 83.8% and the five Central Asian states up 91%. Processing trade rose 36.5% to 131.1 billion yuan, lifting its share 5.7 points to 24.9%. The global-south growth rates are the point: the fastest gains are in the markets least exposed to US remedy machinery.

The counter-signal is that the relay capacity doing the diversifying is precisely what the multi-country cases now target. When Commerce names China alongside Malaysia and Turkey (corrugated pizza boxes) or China with Canada, India, Korea and Mexico (linear hydraulic cylinders) ⁷, an exporter in Penang or Guadalajara carries duty risk regardless of origin. Liaoning's double-digit processing-trade boom is the same phenomenon viewed from the other side: the integration Beijing wants and the exposure Washington can reach are one and the same channel.

Beijing keeps its own remedies in play as counter-leverage. MOFCOM's Announcement No. 37 found Japanese dichlorosilane — a chip-film deposition precursor — dumped with material injury and a causal link, imposing provisional cash-deposit measures from 8 September ⁸. The pecan case against Mexico and the US was extended to 25 March 2027 on grounds of complexity ⁹. Both target upstream and agricultural inputs, not just consumer goods, showing the retaliation set is broadening.

The domestic mirror is also sharpening. Liaoning launched a consumption-promotion month from 15 September to 15 October tied to its investment and trade fair, mobilizing 25,000 merchants across nine scenarios ¹⁰, while CIFTIS closed in Beijing on 13 September after nearly 100 conferences and 1,800 exhibitors ¹¹. The turn toward household demand at home and services abroad is the deliberate complement to an export push that is outrunning its overseas receptivity. Net: momentum is strong and shifting south and west, but the fastest-growing relay markets are exactly where the newest US instruments — retroactive critical-circumstances findings included — now aim.